Fusions between dendritic cells and whole tumor cells as anticancer vaccines
Authors:
Open Access
- 1 May 2013
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 2 (5) , e24437
Abstract
Various strategies have been developed to deliver tumor-associated antigens (TAAs) to dendritic cells (DCs). Among these, the fusion of DCs and whole cancer cells can process a broad array of TAAs,...Keywords
This publication has 16 references indexed in Scilit:
- Combined TLR2/4-Activated Dendritic/Tumor Cell Fusions Induce Augmented Cytotoxic T LymphocytesPLOS ONE, 2013
- Characterization of Structure and Direct Antigen Presentation by Dendritic/Tumor-fused Cells as Cancer Vaccines2013
- Regulation of Tumor Immunity by Tumor/Dendritic Cell FusionsJournal of Immunology Research, 2010
- Cell fusion: from hybridoma to dendritic cell-based vaccineExpert Review of Vaccines, 2008
- Synergistic Induction of Antigen-Specific CTL by Fusions of TLR-Stimulated Dendritic Cells and Heat-Stressed Tumor CellsThe Journal of Immunology, 2007
- Dendritic Cells Fused with Allogeneic Colorectal Cancer Cell Line Present Multiple Colorectal Cancer–Specific Antigens and Induce Antitumor Immunity against Autologous Tumor CellsClinical Cancer Research, 2005
- The Kinetics of In Vivo Priming of CD4 and CD8 T Cells by Dendritic/Tumor Fusion Cells in MUC1-Transgenic MiceThe Journal of Immunology, 2002
- Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell responseProceedings of the National Academy of Sciences, 2000
- Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.Journal of Experimental Medicine, 1996
- Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.Journal of Experimental Medicine, 1996